Navigation Links
Total Protein - Diabetic Disease: Small Intestine: Jejunum from BioChain

ProductsTotal Protein - Diabetic Disease: Small Intestine: Jejunum from BioChain
Company BioChain
Item Total Protein - Diabetic Disease: Small Intestine: Jejunum
Price $309.00
Description Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available.
Info BioChainBioChain
BioChain Institute, Inc.
3517 Breakwater Avenue
Hayward, CA 94545 USA



Call BioChain to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-510-342-5324
Customer Service: 510.783.8588
Fax Number: 510.783.5386
Web Site: http://www.biochain.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Northern BoundTM Human Alzheimers Total RNA Blot from Sigma-Aldrich
2. Total antioxidant capacity Colorimetric Assay Kit from Neogen Corporation
3. Total Antioxidant Power Colorimetric Assay Kit from Neogen Corporation
4. Agilent Total RNA Isolation Mini Kit from Agilent Technologies
5. Total Protein Western Blots - Plant Normal Tissue, Blot I from BioChain
6. Total Protein - Diabetic Disease: Esophagus from BioChain
7. Total Protein - Alzheimers Disease: Brain: Pons from BioChain
8. Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.
9. Mouse MMP-9 (Total) ELISpot Kit from R&D Systems
10. Human MMP-7 (Total) ELISpot Kit from R&D Systems
11. Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
HSV 1 IgG...
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody...
... adds two new Stem Cell Antibody Panels ... products. The Human Embryonic Stem Cell Marker ... antibodies against: alkaline phosphatase, Nanog, Oct-3/4, SSEA-1 ... Marker Antibody Panel Plus (Catalog # SC009) ...
Request Info...
Biology Products:
(Date:11/21/2014)... Nov. 20, 2014 C-Labs LLC, a leading ... of Things (IoT), today announced the appointment of ... officer. Previously a strategic advisor to the firm, Mr. ... Mr. Traynor is based out of the C-Labs office ... to Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... Nov. 18, 2014  The Secure Identity & ... today jointly announce the formation of The Airport ... its Identity and Biometric Entry and Exit ... received official support from BORDERPOL, the international non-profit ... and provide expertise regarding border security, traveler and ...
(Date:11/18/2014)... BETHESDA, Md. , Nov. 17, 2014 The ... European and U.S. regulatory agencies will speak and at least ... Quality Metrics Conference at the Omni Shoreham Hotel in ... is pleased once again to have significant support from the ... and Europe in our effort to ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... Over the past decade various pieces of the puzzle ... Now, in Cell an international team reports ... Their results show that interaction with a linear ubiquitin ... Their findings may also contribute towards structure-based drug design ...
... MADISON The adage that dead men tell no tales ... science is taking interrogation of the dead to new heights. ... into the earliest European visitors to the New World, a ... the chemical details of life history from the teeth of ...
... Alcohol-related deaths in England and Wales are twice as high ... rest of the population, a study has shown. Research, ... National Statistics, also found that men born in India ... of alcohol-related death as Scottish- and Irish-born people. The ...
Cached Biology News:A paradigm shift in immune response regulation 2A paradigm shift in immune response regulation 3Teeth of Columbus' crew flesh out tale of new world discovery 2Teeth of Columbus' crew flesh out tale of new world discovery 3Scots and Irish at greater risk of drink-related death, study shows 2
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
(Date:12/22/2014)... Md. , Dec. 22, 2014 /PRNewswire/ ... SYN), a developer of pathogen-specific therapies for ... on protecting the microbiome, today announced positive ... Phase 1a clinical trial of SYN-004, the ... prevention of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... VIEJO, Calif. , Dec. 22, 2014  ( ... that CoPatient, an online medical bill review and advocacy ... offering in the FREE WellCard Savings discount health services ... medical bill that was more than they expected to ... members reduce health care costs, WellCard Savings is pleased ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3